The pathogenesis of measles revisited

Pediatric Infectious Disease Journal

Volumn 27, Issue SUPPL. 10, 2008, Pages

  De Swart, Rik L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CD150; Dendritic cells; Lymphocytes; Morbillivirus; SLAM

Indexed keywords

CD150 ANTIGEN; CD209 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; DC-SPECIFIC ICAM-3 GRABBING NONINTEGRIN; LECTIN; LEUKOCYTE ANTIGEN; MEASLES VACCINE; VIRUS RECEPTOR;

ANIMAL; ARTICLE; DENDRITIC CELL; DISEASE MODEL; DISEASE TRANSMISSION; EPITHELIUM CELL; HUMAN; LYMPHOCYTE; MEASLES; MEASLES VIRUS; METABOLISM; PATHOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD; CELL ADHESION MOLECULES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HUMANS; LECTINS, C-TYPE; LYMPHOCYTES; MEASLES; MEASLES VACCINE; MEASLES VIRUS; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; VIRUS REPLICATION;

EID: 56149110154     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31816857fe     Document Type: Conference Paper

References (58)

1. De Quadros CA, Izurieta H, Carrasco P, Brana M, Tambini G. Progress toward measles eradication in the region of the Americas. J Infect Dis. 2003;187(Suppl 1):S102-S110. (Pubitemid 36583941)
2. World Health Organziation. Progress in reducing global measles deaths: 1999-2004. Wkly Epidemiol Rec. 2006;81:90-94.
3. Griffin DE. Measles virus. In: Knipe DM, Howley PM, eds. Fields Virology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007:1551-1585.
4. Rima BK, Duprex WP. Morbilliviruses and human disease. J Pathol. 2006;208:199-214. (Pubitemid 43126113)
5. Duke T, Mgone CS. Measles: not just another viral exanthem. Lancet. 2003;361:763-773. (Pubitemid 36293634)
6. Foege WH, Leland OS, Mollohan CS, Fulginiti VA, Henderson DA, Kempe CH. Inactivated measles-virus vaccine. Publ Health Rep. 1965;80:60-64.
7. Fulginiti VA, Eller JJ, Downte AW, Kempe CH. Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA. 1967;202:1075-1080.
8. Graham BS. Pathogenesis of respiratory syncytial virus vaccineaugmented pathology. Am J Respir Crit Care Med. 1995;152:S63-S66.
9. Polack FP, Auwaerter PG, Lee SH, et al. Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med. 1999;5:629-634. (Pubitemid 29289425)
10. Pütz MM, Bouche FB, De Swart RL, Muller CP. Experimental vaccines against measles in a world of changing epidemiology. Int J Parasitol. 2003;33:525-545. (Pubitemid 36638535)
11. World Health Organization. Measles vaccines. Wkly Epidemiol Rec. 2004;79:130-142.
12. Valdespino-Gomez JL, De Lourdes Garcia-Garcia M, Fernandez de Castro J, Henao-Restrepo AM, Bennett J, Sepulveda-Amor J. Measles aerosol vaccination. Curr Top Microbiol Immunol. 2006;304:165-193. (Pubitemid 47413296)
13. Stittelaar KJ, De Swart RL, Osterhaus ADME. Vaccination against measles: a neverending story. Expert Rev Vaccines. 2002;1:151-159. (Pubitemid 36686865)
14. Moss WJ, Griffin DE. Global measles elimination. Nat Rev Microbiol. 2006;4:900-908. (Pubitemid 44768252)
15. van Binnendijk RS, van der Heijden RW, Osterhaus AD. Monkeys in measles research. Curr Top Microbiol Immunol. 1995;191:135-148.
16. Naniche D, Varior-Krishnan G, Cervoni F, et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol. 1993;67:6025-6032. (Pubitemid 23277513)
17. Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 1993;75:295-305. (Pubitemid 23320293)
18. Buckland R, Wild TF. Is CD46 the cellular receptor for measles virus? Virus Res. 1997;48:1-9. (Pubitemid 27163263)
19. Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature. 2000;406:893-897. (Pubitemid 30664265)
20. Yanagi Y, Takeda M, Ohno S. Measles virus: cellular receptors, tropismand pathogenesis. J Gen Virol. 2006;87:2767-2779. (Pubitemid 44463885)
21. World Health Organization. Manual for the Laboratory Diagnosis of Measles and Rubella Virus Infection. 2nd ed. Geneva, Switzerland: WHO/IVB/07.01; 2007.
22. De Witte L, Abt M, Schneider-Schaulies S, Van Kooyk Y, Geijtenbeek TBH. Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol. 2006;80:3477-3486.
23. Gringhuis SI, Den Dunnen J, Litjens M, Van het Hof B, Van Kooyk Y, Geijtenbeek TB. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kB. Immunity. 2007;26:605-616. (Pubitemid 46756345)
24. Hashimoto K, Ono N, Tatsuo H, et al. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol. 2002;76:6743-6749. (Pubitemid 34633540)
25. Andres O, Obojes K, Kim KS, Ter Meulen V, Schneider-Schaulies J. CD46- and CD150-independent endothelial cell infection with wild-type measles viruses. J Gen Virol. 2003;84:1189-1197. (Pubitemid 36603297)
26. Takeda M, Tahara M, Hashiguchi T, et al. A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via SLAMand CD46-independent mechanism. J Virol. 2007;81:12091-12096. (Pubitemid 47623842)
27. Shingai M, Inoue N, Okuno T, et al. Wild-type measles virus infection in human CD46/CD150-transgenic mice: CD11c-positive dendritic cells establish systemic viral infection. J Immunol. 2005; 175:3252-3261. (Pubitemid 41170546)
28. Welstead GG, Iorio C, Draker R, et al. Measles virus replication in lymphatic cells and organs of CD150 (SLAM) transgenic mice. Proc Natl Acad Sci USA. 2005;102:16415-16420. (Pubitemid 41688928)
29. Sellin CI, Davoust N, Guillaume V, et al. High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice. J Virol. 2006;80:6420-6429. (Pubitemid 43927445)
30. Ohno S, Ono N, Seki F, et al. Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection. J Virol. 2007;81:1650-1659. (Pubitemid 46214440)
31. Wyde PR, Moore-Poveda DK, Daley NJ, Oshitani H. Replication of clinical measles virus strains in hispid cotton rats. Proc Soc Exp Biol Med. 1999;221:53-62.
32. Niewiesk S. Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus). Vaccine. 2001;19:2250-2253. (Pubitemid 32234222)
33. Niewiesk S, Eisenhuth I, Ter Meulen V. Protective immunity, but suppressed immune responses to third party antigens are generated in cotton rats during measles virus infection. Biochem Soc Trans. 1997;25:355S.
34. Anderson JF, Goldberger J. Experimental measles in the monkey: a supplemental note. Publ Health Rep. 1911;26:887-895.
35. Kobune F, Takahashi H, Terao K, et al. Nonhuman primate models of measles. Lab Anim Sci. 1996;46:315-320. (Pubitemid 126492188)
36. McChesney MB, Miller CJ, Rota PA, et al. Experimental measles I. Pathogenesis in the normal and the immunized host. Virology. 1997;233: 74-84. (Pubitemid 27348769)
37. Summers BA, Appel MJ. Aspects of canine distemper virus and measles virus encephalomyelitis. Neuropathol Appl Neurobiol. 1994;20:525-534.
38. Von Messling V, Springfeld C, Devaux P, Cattaneo R. A ferret model of canine distemper virus virulence and immunosuppression. J Virol. 2003; 77:12579-12591. (Pubitemid 37430654)
39. Esolen LM, Ward BJ, Moench TR, Griffin DE. Infection of monocytes during measles. J Infect Dis. 1993;168:47-52. (Pubitemid 23178728)
40. Griffin DE, Ward BJ, Esolen LM. Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis. 1994; 170(Suppl 1):S24-S31. (Pubitemid 24322527)
41. Hilleman MR. Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications. Vaccine. 2001;20: 651-665. (Pubitemid 34015806)
42. Minagawa H, Tanaka K, Ono N, Tatsuo H, Yanagi Y. Induction of the measles virus receptor SLAM (CD150) on monocytes. J Gen Virol. 2001;82:2913-2917. (Pubitemid 33107504)
43. Takeuchi K, Miyajima N, Nagata N, Takeda M, Tashiro M. Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)-independent mechanism. Virus Res. 2003;94:11-16. (Pubitemid 36776741)
44. Yamanouchi K, Chino F, Kobune F, Kodama H, Tsuruhara T. Growth of measles virus in the lymphoid tissues of monkeys. J Infect Dis. 1973; 128:795-799.
45. Sullivan JL, Barry DW, Lucas SJ, Albrecht P. Measles infection of human mononuclear cells. I. Acute infection of peripheral blood lymphocytes and monocytes. J Exp Med. 1975;142:773-784.
46. De Swart RL, Ludlow M, De Witte L, et al. Predominant infection of CD150 lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog. 2007;3:e178.
47. Von Messling V, Milosevic D, Cattaneo R. Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci USA. 2004;101:14216-14221. (Pubitemid 39305056)
48. Condack C, Grivel J-C, Devaux P, Margolis L, Cattaneo R. Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J Infect Dis. 2007;196:541-549. (Pubitemid 47206100)
49. Schnorr J-J, Xanthakos S, Keikavoussi P, Kämpgen E, Ter Meulen V, Schneider-Schaulies S. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci USA. 1997;94:5326-5331. (Pubitemid 27214782)
50. Grosjean I, Caux C, Bella C, et al. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+T cells. J Exp Med. 1997;186:801-812. (Pubitemid 27407342)
51. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan M-C, Liu Y-J, Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med. 1997;186:813-823. (Pubitemid 27407343)
52. Global Programme for Vaccines and immunization/Expanded Programme on Immunization. Using Surveillance Data and Outbreak Investigations to Strengthen Measles Immunization Programmes (WHO/EPI/GEN/96.02). Geneva, Switzerland: World Health Organization; 1996.
53. Durrheim DN, Kelly H, Ferson MJ, Featherstone D. Remaining measles challenges in Australia. Med J Aust. 2007;187:181-184. (Pubitemid 47307675)
54. Featherstone D, Brown D, Sanders R. Development of the global measles laboratory network. J Infect Dis. 2003;187(Suppl 1):S264-S269. (Pubitemid 36583965)
55. Nokes DJ, Enquselassie F, Vyse A, Nigatu W, Cutts FT, Brown DW. An evaluation of oral-fluid collection devices for the determination of rubella antibody status in a rural Ethiopian community. Trans R Soc Trop Med Hyg. 1998;92:679-685. (Pubitemid 29015230)
56. De Swart RL, Nur Y, Abdallah A, et al. Combination of reverse transcriptase PCR analysis and immunoglobulin M detection on filter paper blood samples allows diagnostic and epidemiological studies of measles. J Clin Microbiol. 2001;39:270-273. (Pubitemid 32059602)
57. Jin L, Vyse A, Brown DW. The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella. Bull World Health Organ. 2002;80:76-77. (Pubitemid 34151513)
58. Van Binnendijk RS, Van den Hof S, Van den Kerkhof H, et al. Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infections during an outbreak of measles in The Netherlands. J Infect Dis. 2003;188:898-903. (Pubitemid 37176037)